Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia
about
Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infantsEarly (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infantsLate (>7 days) postnatal corticosteroids for chronic lung disease in preterm infantsModerately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infantsPostnatal corticosteroids in preterm infants: systematic review of effects on mortality and motor function.Postnatal glucocorticosteroid therapy for treatment and prevention of neonatal chronic lung disease.Bronchopulmonary dysplasia (chronic lung disease of infancy): an update for the pediatrician.Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease.Pulse dexamethasone does not impair growth and body composition of very low birth weight infants.The role of corticosteroids in respiratory diseases of children.Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.Serum cortisol, dehydroepiandrosterone sulfate, and steroid-binding globulins in preterm neonates: effect of gestational age and dexamethasone therapy.Exhaled nitric oxide at school age in prematurely born infants with neonatal chronic lung disease.Changes of the physiological parameters of very low-birthweight infants with chronic lung disease treated with dexamethasone.
P2860
Q24194676-4F743FDB-FE03-4344-AE6C-6D1D82FE6970Q24194710-3C81C1FA-2C5F-4948-99F1-4132647EAB47Q24241502-95572F03-F0BA-4DA9-A03F-FA014790E62BQ24250284-BF990FFE-A3C5-49E2-9127-883E621282C6Q33888778-085681E7-17CF-4B4C-B86A-488EDAC321F0Q34074665-F90E9E62-8FEE-4822-99CD-544E941E107FQ34586484-DBB0BD77-2D25-40A0-AB54-0813A52D3631Q35287062-25514335-98F2-4BB2-A1F4-FFE77033EFF0Q36786406-30D3627D-8E81-4137-AA66-D3A1970AD049Q41151318-9CADCA02-5B53-4930-95EB-A03FC05CBA89Q47235829-EABD93FD-1261-4552-81E3-4D8643CC8C91Q47235844-311A6CB5-A000-47BE-8D8A-6805DBF416D8Q51006859-391BA1D0-41F8-40F5-9A5B-B624475D9CC5Q51720938-C7CA7381-D633-4CC7-9D0D-E8A1CB7E269DQ51723903-5E9E0E70-875F-4759-8804-555E60076D8F
P2860
Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia
description
1993 nî lūn-bûn
@nan
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
name
Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia
@ast
Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia
@en
type
label
Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia
@ast
Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia
@en
prefLabel
Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia
@ast
Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia
@en
P2093
P2860
P921
P1476
Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia
@en
P2093
P2860
P304
P356
10.1136/ADC.68.5_SPEC_NO.566
P407
P433
P577
1993-05-01T00:00:00Z